KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Prepaid Assets (2016 - 2025)

Biogen (BIIB) has 17 years of Prepaid Assets data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 49.28% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 49.28%, while the annual FY2025 figure was $1.1 billion, 49.28% up from the prior year.
  • Prepaid Assets reached $1.1 billion in Q4 2025 per BIIB's latest filing, up from $916.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.6 billion in Q2 2022 and bottomed at $615.3 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $991.8 million, with a median of $906.4 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: surged 114.26% in 2022, then plummeted 45.55% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $740.8 million in 2021, then skyrocketed by 91.36% to $1.4 billion in 2022, then decreased by 16.62% to $1.2 billion in 2023, then crashed by 36.34% to $752.5 million in 2024, then surged by 49.28% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $1.1 billion in Q4 2025, $916.8 million in Q3 2025, and $850.6 million in Q2 2025.